Clinical Trial Update: Livial Intervention Following Breast Cancer; Efficacy, Recurrence and Tolerability Endpoints (LIBERATE)(COMPLETED)(P05885) [Phase 3]

View source ↗

Summary

Phase 3 trial update for LIBERATE evaluating livial intervention after breast cancer, reporting efficacy, recurrence, and tolerability endpoints.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Livial (tibolone)

Snippet

Sponsor: Organon and Co | Conditions: Breast Cancer, Climacteric Symptoms | Phase 3 | Status: COMPLETED